Morphic Story

<div class='circular--portrait' style='background:#FF6600;color: #f7f7f7;font-size:4em;'>MH</div>
MORF -- USA Stock  

USD 32.50  0.13  0.40%

Let's try to digest what's happening with Morphic Holding amid unprecedented political, and economic uncertainty. Morphic Holding is now traded for 29.51. The entity has historical hype elasticity of 0.12. The average price elasticity to hype of competition is about -0.03. The firm is expected to increase in value after the next press release, with the price going to jump to 29.63. The latest volatility of headline impact on the company stock price is is way over 100 percent making price predictions on social media along less reliable. The price growth on the next news is estimated to be 0.41%, whereas the daily expected return is now at 0.29%. Given the investment horizon of 30 days, the next expected announcement will be in about 5 days.
Published over two months ago
View all stories for Morphic Holding | View All Stories
Is Morphic Holding (NASDAQ:MORF) gaining more confidence from shareholders?
Our advice module complements current analysts and expert consensus on Morphic Holding. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time.
The successful prediction of Morphic Holding stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Morphic Holding, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Morphic Holding based on Morphic Holding hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to Morphic Holding's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Morphic Holding's related companies.

Use Technical Analysis to project Morphic expected Price

Morphic Holding technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Morphic Holding technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Morphic Holding trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How Morphic utilizes its cash?

To perform a cash flow analysis of Morphic Holding, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Morphic Holding is receiving and how much cash it distributes out in a given period. The Morphic Holding cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Morphic Holding Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (37.49 Million)

What is the case for Morphic Holding Investors

This firm reported the previous year's revenue of 38.71 M. Net Loss for the year was (47.08 M) with loss before overhead, payroll, taxes, and interest of (36.76 M).

Deferred Revenue Breakdown

Morphic Holding Deferred Revenue is decreasing over the years with slightly volatile fluctuation. Deferred Revenue is expected to dwindle to about 89.9 M. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Morphic Holding Deferred Revenue is projected to decrease significantly based on the last few years of reporting. The past year's Deferred Revenue was at 94.4 Million
201096.64 Million
201994.4 Million
202089.91 Million

Our perspective of the latest Morphic Holding surge

Latest Total Risk Alpha is up to -0.06. Price may dip again. As of the 25th of November, Morphic Holding secures the Risk Adjusted Performance of 0.0716, mean deviation of 2.46, and Downside Deviation of 3.14. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Morphic Holding, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for Morphic Holding, which can be compared to its peers in the industry. Please verify Morphic Holding variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Morphic Holding is priced some-what accurately, providing market reflects its recent price of 29.51 per share. Given that Morphic Holding has jensen alpha of 0.181, we recommend you to check Morphic Holding's last-minute market performance to make sure the company can sustain itself at a future point.

Our Bottom Line On Morphic Holding

Although many of the other players within the biotechnology industry are still a little expensive, even after the recent corrections, Morphic Holding may offer a potential longer-term growth to shareholders. To conclude, as of the 25th of November 2020, we believe that at this point, Morphic Holding is fairly valued with below average chance of financial distress within the next 2 years. However, our actual 'Buy-vs-Sell' recommendation on the firm is Strong Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Morphic Holding. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to